BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Overview Fund Activity
Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

8 hedge funds and large institutions have $6.4M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.

Holders
8
Holders Change
-4
Holders Change %
-33.33%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
BC
1
Brookfield Corp
Ontario, Canada
$0
2
TNB
2
Thomasville National Bank
Georgia
$0
3
WAM
3
Westport Asset Management
Connecticut
$0
4
IAIM
4
International Assets Investment Management
Florida
$0
Name Market Value Shares Shares
Change 		Shares
Change %
JCI
1
Jet Capital Investors
New York
$3.46M 2,661,301 – –
Tudor Investment Corp
2
Tudor Investment Corp
Connecticut
$2.94M 2,264,818 – –
BC
3
Brookfield Corp
Ontario, Canada
– – -400,000 Closed
TNB
4
Thomasville National Bank
Georgia
– – -38,459 Closed
WAM
5
Westport Asset Management
Connecticut
– – -10,000 Closed
MI
6
Markston International
New York
– – -3,673 Closed
IAIM
7
International Assets Investment Management
Florida
– – -2,375 Closed
BCM
8
Beddow Capital Management
Wyoming
$0 570,289 -1,500 -0.3%
CAM
9
Close Asset Management
United Kingdom
– – -200 Closed
PDN
10
Pensionfund DSM Netherlands
Netherlands
$0 33,000 – –
RMC
11
Resources Management Corp
Connecticut
$0 10 – –
PS
12
Pensionfund Sabic
Netherlands
$0 23,000 – –
MAM
13
Meeder Asset Management
Ohio
$0 5 +5 New
DLA
14
Douglas Lane & Associates
New York
$0 10,000 +10,000 New